Oncothyreon Inc.·4

Dec 16, 5:02 PM ET

Oncothyreon Inc. 4

4 · Oncothyreon Inc. · Filed Dec 16, 2013

Insider Transaction Report

Form 4
Period: 2013-12-12
KIRKMAN ROBERT L
DirectorPresident/CEO
Transactions
  • Award

    Stock Option (right to buy)

    2013-12-12+600,000600,000 total
    Exercise: $1.74Exp: 2021-12-12Common Stock (600,000 underlying)
Footnotes (1)
  • [F1]The option vests and is exercisable at the rate of 1/4th of the total shares on December 12, 2014 and then 1/48th of the total shares vest and are exercisable monthly thereafter, with 100% vested and exercisable on December 12, 2017.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION